ASC, TBS, and the power of ALTS

American Journal of Clinical Pathology

Volumn 127, Issue 4, 2007, Pages 489-491

  Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DAMAGE; COLPOSCOPY; CYTOPATHOLOGY; DIAGNOSTIC TEST; EDITORIAL; HUMAN; LABORATORY TEST; PAPANICOLAOU TEST; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIALS; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; TERMINOLOGY; UTERINE CERVICAL NEOPLASMS;

EID: 34247175450     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/J31A0YQM37Q4V4KK     Document Type: Editorial

References (13)

1. Lee C Y-K, Ng W-K. A follow-up study of atypical squamous cells in gynecologic cytology using conventional Papanicolaou smears and liquid-based preparations: the impact of the Bethesda System 2001. Am J Clin Pathol. 2007;127:548-555.
2. Stoler MH. Does every little cell count? Don't "ASCUS" [editorial]. Cancer. 1999;87:45-47.
3. Stoler MH. Toward objective quality assurance: the eyes don't have it [editorial]. Am J Clin Pathol. 2002;117:520-522.
4. Stoler MH. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings [editorial]. JAMA. 2002;287:2140-2141.
5. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505.
6. Sherman ME, Solomon D, Schiffman M, for the ASCUS-LSIL Triage Study Group. Qualification of ASCUS: a comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS-LSIL Triage Study. Am J Clin Pathol. 2001;116:386-394.
7. Davey DD, Neal MH, Wilbur DC, et al. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004;128:1224-1229.
8. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188:1393-1400.
9. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188:1383-1392.
10. Cox JT, Schiffman M, Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188:1406-1412.
11. Guido R, Schiffman M, Solomon D, et al. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol. 2003;188:1401-1405.
12. Irvin WP Jr, Andersen WA, Taylor PT Jr, et al. "See-and-treat" loop electrosurgical excision: has the time come for a reassessment? J Reprod Med. 2002;47:569-574.
13. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095-1101.